Dan Li

Prof. Dr. Dan Li

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
GLGanghua Lu
Ganghua Lu
DGDingwei Gao
Dingwei Gao
WJWen Jiang
Wen Jiang
XYXiaqing Yu
Xiaqing Yu
JTJunyu Tong
Junyu Tong
ZLzhongwei Lv
zhongwei Lv
Background: Despite the potential radiotoxicity in differentiated thyroid cancer (DTC) patients with high-dose 131I therapy, the alterations and regulatory mechanisms dependent on intestinal microecology remain poorly understood. We aimed to identify the characteristics of the gut microbiota and metabolites in DTC patients suffering from high-dose 131I therapy and explore the radioprotective mechanisms underlying arachidonic acid (ARA) treatment. Methods: A total of 102 patients with DTC were recruited, with fecal samples collected before and after 131I therapy for microbiome and untargeted and targeted metabolomic analyses. Mice were exposed to total body irradiation with ARA replenishment and antibiotic pretreatment and were subjected to metagenomic, metabolomic, and proteomic analyses. Results: 131I therapy significantly changed the structure of gut microbiota and metabolite composition in patients with DTC. Lachnospiraceae were the most dominant bacteria after 131I treatment, and metabolites with decreased levels and pathways related to ARA and linoleic acid were observed. In an irradiation mouse model, ARA supplementation not only improved quality of life and recovered hematopoietic and gastrointestinal systems but also ameliorated oxidative stress and inflammation and preserved enteric microecology composition. Additionally, antibiotic intervention eliminated the radioprotective effects of ARA. Proteomic analysis and ursolic acid pretreatment showed that ARA therapy greatly influenced intestinal lipid metabolism in mice subjected to irradiation by upregulating the expression of hydroxy-3-methylglutaryl-coenzyme A synthase 1. Conclusion: These findings highlight that ARA, as a key metabolite, substantially contributes to radioprotection. Our study provides novel insights into the pivotal role that the microbiota-metabolite axis plays in radionuclide protection and offers effective biological targets for treating radiation-induced adverse effects.

8 September 2023 in Abdominal Radiology
Verified
Journal Article
Open access
PDF file
YYYuping Yin
Yuping Yin
JLJiachen Liu
Jiachen Liu
RSRunlu Sun
Runlu Sun
XLXuming Liu
Xuming Liu
ZZZhangchi Zhou
Zhangchi Zhou
DLDan Li
Dan Li
Purpose: The sensitivity of [18F] fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for detecting hepatocellular carcinoma (HCC) has not been clarified thoroughly. Our study seeks to explore the association between the Ki-67 index and FDG-avidity in HCC tumors using 18F-FDG PET/CT. Methods: 112 HCC lesions from 109 patients detected by 18F-FDG PET/CT were included retrospectively between August 2017 and May 2022, comprising 82 lesions in the training cohort and 30 in the validation cohort to simulate prospective studies. In the training cohort, lesions were stratified by a lesion-to-liver maximum standardized uptake value (SUVmax) ratio cut-off of 1.59. The relationships between lesion-to-liver SUVmax ratios and several clinical factors including tumor differentiation, alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), hepatitis B virus (HBV) infection, Ki-67 index et al. were assessed. These findings were subsequently validated in the independent validation cohort. Results: In the training cohort, group A1 lesions demonstrated a higher Ki-67 index (%, 40.00 [30.00, 57.50] vs. 10.00 [5.00, 28.75], p<0.001) than group A0, the positive correlation between FDG-avidity and Ki-67 index was revealed by multivariate analysis, OR=1.040, 95% CI of OR [1.004–1.077], p=0.030. The calculated cut-off value was 17.5% using the receiver operating characteristic (ROC) curve, with an area under curve (AUC) of 0.834 and 95% CI [0.742–0.926], p<0.001. These findings were further validated in the independent validation cohort, with similar results (AUC=0.875, 95% CI [0.750–1.000], p<0.001). Conclusion: In comparison to tumor differentiation, Ki-67 index demonstrates a stronger association with FDG-avidity in HCC tumors, and when the Ki-67 index exceeds 17.5%, 18F-FDG PET/CT might serve as a useful indicator for HCC. Graphical

1 October 2024 in Radioprotection
Verified
Journal Article
Open access
PDF file
JYJy. Yan
Jy. Yan
DLDan Li
Dan Li
The multifaceted applications of nuclear technology, especially in cancer treatment through radiotherapy, bring considerable benefits to our daily lives but also necessitate the imperative for effective strategies to effectively mitigate radiation-induced issues. While strict compliance with usage specifications is essential, ensuring proper protection against radiation-induced damages is crucial. Selenium, in its various forms including selenomethionine, Ebselen, and sodium selenite, emerges as a promising radioprotective agent with demonstrated efficacy across diverse radiation-injured organs, highlighting its significance as an effective and potent antioxidant that affordable for most patients. Abundant experiments have exhibited the capacity of selenium-containing compounds and metabolites to function as valuable radioprotective adjuvants, emphasizing their potential in safeguarding against the adverse effects of radiation exposure. To harness the full radioprotective potential of selenium, further research is needed to optimize selenium supplementation strategies, taking into account factors such as timing and dosage, particularly in the context of radiotherapy.

21 April 2026 in EJNMMI Radiopharmacy and Chemistry
Verified
Journal Article
Open access
PDF file
XWXiaoting Wan
Xiaoting Wan
JYJiangyue Yan
Jiangyue Yan
JHJieting Hu
Jieting Hu
RZRuiyun Zhang
Ruiyun Zhang
SZShiliang Zhu
Shiliang Zhu
DLDan Li
Dan Li
Neuroendocrine neoplasms (NENs) represent heterogeneous tumors with increasing occurrence rate. Somatostatin receptor (SSTR) imaging using 68Ga-labeled ana